Niklas Tevajärvi
Comptroller/Controller/Auditor at Encorium Group, Inc.
Profile
Niklas Tevajärvi is currently working as the Chief Accounting Officer at Encorium Group, Inc. since 2011.
He is also currently serving as the Chief Financial Officer at Encorium Oy since 2010.
Mr. Tevajärvi has a graduate degree from Hanken Svenska Handelshögskolan.
Niklas Tevajärvi active positions
| Companies | Position | Start |
|---|---|---|
Encorium Group, Inc.
 Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Comptroller/Controller/Auditor | 27/10/2011 |
| Encorium Oy | Director of Finance/CFO | 27/10/2011 |
Training of Niklas Tevajärvi
| Hanken Svenska Handelshögskolan | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Commercial Services |
| Encorium Oy |
- Stock Market
- Insiders
- Niklas Tevajärvi
